China Pharma Holdings (CPHI) Receivables (2010 - 2026)
China Pharma Holdings' (CPHI) quarterly Receivables came in at $257919.0 in Q1 2026, down 29.9% YoY from $367947.0 in Q1 2025, and down 15.07% on a QoQ basis from $303696.0 in Q4 2025.
China Pharma Holdings (CPHI) Receivables (2010 - 2026) Analysis & Trends
China Pharma Holdings (CPHI) has 17 years of Receivables data on file, last reported at $257919.0 in Q1 2026.
- Quarterly Receivables fell 29.9% year-over-year to $257919.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $257919.0 (down 29.9% YoY) and the FY2025 annual result came in at $303696.0, down 97.81% from the prior year.
- Receivables fell to $257919.0 in Q1 2026, from $303696.0 in the prior quarter.
- In the past five years, Receivables ranged from a high of $14.4 million in Q4 2023 to a low of $91753.0 in Q2 2023.
- A 5-year average of $3.7 million and a median of $397156.0 in 2023 frame the typical range for Receivables.
- The widest YoY moves for Receivables: up 13093.89% in 2024, down 98.18% in 2024.
- Tracing CPHI's Receivables over 5 years: stood at $450670.0 in 2022, then jumped by 3106.0% to $14.4 million in 2023, then plunged by 98.18% to $262426.0 in 2024, then gained by 15.73% to $303696.0 in 2025, then decreased by 15.07% to $257919.0 in 2026.
- The last three Receivables figures came in at $257919.0 (Q1 2026), $303696.0 (Q4 2025), and $285913.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 3.07 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 3.49 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 1.57 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 5.84 Bn |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 310.30 Mn |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | 3.67 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 887.00 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 1.15 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 1.08 Bn |
| 10 | China Pharma Holdings | 42.70 Mn | 42.39 Mn | 83,566.00 | 262,476.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 257,919.00 |
| Dec 31, 2025 | 303,696.00 |
| Sep 30, 2025 | 285,913.00 |
| Jun 30, 2025 | 13.96 Mn |
| Mar 31, 2025 | 367,947.00 |
| Dec 31, 2024 | 262,426.00 |
| Sep 30, 2024 | 14.32 Mn |
| Jun 30, 2024 | 283,510.00 |
| Mar 31, 2024 | 14.15 Mn |
| Dec 31, 2023 | 14.45 Mn |
| Sep 30, 2023 | 397,156.00 |
| Jun 30, 2023 | 91,753.00 |
| Mar 31, 2023 | 107,254.00 |
| Dec 31, 2022 | 450,670.00 |
| Sep 30, 2022 | 1.14 Mn |
| Jun 30, 2022 | 1.20 Mn |
| Mar 31, 2022 | 1.24 Mn |
| Dec 31, 2021 | 1.45 Mn |
| Sep 30, 2021 | 1.75 Mn |
| Jun 30, 2021 | 1.53 Mn |